Immunomagnetic separation technologies

A.E.L.M. Hoeppener, Joost Franciscus Swennenhuis, Leonardus Wendelinus Mathias Marie Terstappen

Research output: Chapter in Book/Report/Conference proceedingChapterAcademicpeer-review

8 Citations (Scopus)


The largest difficulty one faces in the development of technology for detection of circulating tumor cells (CTCs) is whether or not tumor cells are present in the blood and at what frequency. Although the introduction of the validated CellSearch system for CTC enumeration has facilitated CTC research the question remains whether CTC are missed or whether the CTC that are reported are indeed clinically relevant. To fulfill the promise of CTC as a real-time liquid biopsy they will need to be present in the blood volume tested and need to be isolated without losing the ability to test the presence of treatment targets. To characterize a sufficiently large number of CTCs in the majority of cancer patients the volume of blood needed is simply too large to process without enrichment prior to detection. Here, we review the detection of CTCs by flow cytometry and fluorescence microscopy with and without immunomagnetic enrichment.
Original languageEnglish
Title of host publicationMinimal Residual Disease and Circulating Tumor Cells in Breast Cancer
EditorsM. Ignatiadis, C. Christos Sotiriou, K. Pantel
Publication statusPublished - 2012

Publication series

NameRecent Results in Cancer Research


  • IR-81976
  • METIS-282659

Fingerprint Dive into the research topics of 'Immunomagnetic separation technologies'. Together they form a unique fingerprint.

Cite this